SELLAS Life Sciences Group (SLS) EBT: 2010-2023
Historic EBT for SELLAS Life Sciences Group (SLS) over the last 9 years, with Dec 2023 value amounting to -$37.9 million.
- SELLAS Life Sciences Group's EBT rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
- As of FY2023, SELLAS Life Sciences Group's EBT stood at -$37.9 million, which was up 8.31% from -$41.3 million recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's EBT registered a high of -$16.8 million during FY2020, and its lowest value of -$41.3 million during FY2022.
- In the last 3 years, SELLAS Life Sciences Group's EBT had a median value of -$37.9 million in 2023 and averaged -$33.4 million.
- In the last 5 years, SELLAS Life Sciences Group's EBT climbed by 13.42% in 2020 and then tumbled by 97.27% in 2022.
- Yearly analysis of 5 years shows SELLAS Life Sciences Group's EBT stood at -$19.4 million in 2019, then grew by 13.42% to -$16.8 million in 2020, then dropped by 24.81% to -$20.9 million in 2021, then plummeted by 97.27% to -$41.3 million in 2022, then climbed by 8.31% to -$37.9 million in 2023.